AdipoGen Life Sciences immunosuppressive antibiotics
AdipoGen Life Sciences is a provider of key standard antibiotics, rare metabolites/antibiotics and common immunosuppressive antibiotics for use in research. The company’s common immunosuppressive antibiotics are involved in cell proliferation pathways and include calcineurin (FK-506, cyclosporin A, ascomycin), mTOR (everolimus, rapamycin) and purine synthesis (mycophenolic acid) inhibitors.
Inhibition of calcineurin leads to inhibition of NFAT activation, reduced IL-2 production and consequently to reduced T cell proliferation. Inhibition of mTOR leads to inhibition of the IL-2 mediated cell cycle, which consequently blocks T cell activation, and B cell differentiation. Blockade of purine synthesis by inhibiting inosine monophosphate dehydrogenase (IMPDH) leads to a selective inhibition of lymphocyte proliferation.
Everolimus is a potent immunosuppressive antibiotic that binds with high affinity to the FK-506 binding protein-12 (FKBP12) to generate an immunosuppressive complex that inhibits the activation of the mammalian target of rapamycin (mTOR). Furthermore, it shows anticancer and antibacterial activities. It is sourced from Streptomyces hygroscopicus (Actinobacteria).
Phone: 02 9698 2022
Enzo Life Sciences PROTEOSTAT Protein refolding and aggregation sensing kit
The kit includes a comprehensive set of optimised screening reagents and conditions that...
Bio-Rad Laboratories ddPLEX ESR1 Mutation Detection Kit
The kit enables simultaneous detection, discrimination and absolute quantification of seven known...
AdipoGen Life Sciences InVivoKines recombinant fusion proteins
InVivoKines are recombinant fusion proteins for immunotherapeutic, preclinical and translational...